Biography

Buket Baddal graduated with a BSc degree in Medical Microbiology from University of Surrey in United Kingdom in 2008. Later in 2009, she obtained her MSc degree in Clinical Microbiology from Queen Mary, University of London. Between 2009-2011, she worked as part of the core team in Antimicrobial Resistance and Healthcare Associated Infections Unit at Public Health England. In 2011, Dr. Baddal was awarded the Marie Curie fellowship and started her PhD in Infectious Diseases, working on a collaborative project between GlaxoSmithKline Vaccines and University of Rome in Italy. Her PhD research focused on respiratory tract infections, nontypeable Haemophilus influenzae pathogenesis, transcriptomics and vaccine development. After completion of her PhD in 2015, she joined Harvard Medical School in Boston, Massachusetts for her post-doctoral studies, where she investigated molecular basis of streptococcal infections, mainly focusing on pore-forming toxins streptolysin O and streptolysin S and their role in pathogenesis. In 2017, Dr. Baddal was awarded the ‘Young Investigator Award’ in United States for her work on streptococcal pathogenesis. In 2017-2018, she was appointed as the Project Lead at Emulate Inc., a Harvard University spin-off, where she worked on Organs-on-Chip technology for advancing drug discovery. Dr. Baddal is currently a Senior Lecturer and Researcher in Microbiology in the Department of Pharmaceutical Microbiology, Faculty of Pharmacy at Near East University. She is a member of European Society of Clinical Microbiology and Infectious Diseases, American Society for Microbiology, Turkish Society for Microbiology and Turkish Cypriot Biologists Association for Research and Nature Protection.